MRNA (Moderna, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by MRNA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | — | — |
| 2026-08-31 | Stephen Hoge | President | MIXED | — | — |
| 2026-08-31 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-08-07 | Stephane Bancel | Chief Executive Officer | MIXED | — | — |
| 2026-08-07 | Stephane Bancel | Chief Executive Officer | MIXED | — | — |
| 2026-07-16 | Stephen Hoge | President | MIXED | — | — |
| 2026-07-10 | Michael R. McDonnell | Director | A | — | — |
| 2026-07-07 | Soria Ester Banque | Chief Commercial Officer | A | — | — |
| 2026-07-06 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-06-17 | Stephen Hoge | President | MIXED | — | — |
| 2026-06-08 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | — | — |
| 2026-06-08 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-06-03 | Stephen Hoge | President | MIXED | — | — |
| 2026-06-03 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | — | — |
| 2026-06-03 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-05-29 | Stephen Hoge | President | MIXED | — | — |
| 2026-05-29 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | — | — |
| 2026-05-29 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-05-22 | NOUBAR AFEYAN | Director | MIXED | — | — |
| 2026-05-18 | Stephen Hoge | President | MIXED | — | — |
| 2026-05-08 | NOUBAR AFEYAN | Director | A | — | — |
| 2026-05-08 | Elizabeth E Tallett | Director | A | — | — |
| 2026-05-08 | Francois Nader | Director | A | — | — |
| 2026-05-08 | ELIZABETH G NABEL | Director | A | — | — |
| 2026-05-08 | Sandra Horning | Director | A | — | — |
| 2026-05-08 | Abbas Hussain | Director | A | — | — |
| 2026-05-08 | David M. Rubenstein | Director | A | — | — |
| 2026-05-04 | Elizabeth E Tallett | Director | M | — | — |
| 2026-05-04 | Francois Nader | Director | M | — | — |
| 2026-05-04 | ELIZABETH G NABEL | Director | M | — | — |
| 2026-05-04 | Abbas Hussain | Director | MIXED | — | — |
| 2026-05-04 | David M. Rubenstein | Director | M | — | — |
| 2026-05-04 | Sandra Horning | Director | M | — | — |
| 2026-04-06 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-03-06 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-03-06 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | — | — |
| 2026-03-03 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-03-03 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | — | — |
| 2026-03-03 | Stephen Hoge | President | MIXED | — | — |
| 2026-03-03 | Stephane Bancel | Chief Executive Officer | A | — | — |
| 2026-02-25 | Stephen Hoge | President | MIXED | — | — |
| 2026-02-13 | Stephane Bancel | Chief Executive Officer | MIXED | — | — |
| 2026-02-13 | Stephen Hoge | President | MIXED | — | — |
| 2026-02-13 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | — | — |
| 2026-02-13 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2026-01-06 | James M Mock | Chief Financial Officer | MIXED | — | — |
| 2025-12-15 | Stephane Bancel | Chief Executive Officer | M | — | — |
| 2025-12-15 | NOUBAR AFEYAN | Director | MIXED | — | — |
| 2025-12-11 | Abbas Hussain | Director | Sell | — | — |
| 2025-12-08 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 21,986,399 | — |
| — | Chief Executive Officer | 12,939,715 | — |
| — | Director | 11,481,796 | — |
| — | Director | 2,971,912 | — |
| — | 10%+ Owner | 1,823,036 | — |
| — | President | 1,541,300 | — |
| — | Chief Financial Officer | 1,443,510 | — |
| — | Director | 312,730 | — |
| — | Director | 203,924 | — |
| — | Chief Legal Officer | 79,266 | — |
| — | Chief Financial Officer | 66,436 | — |
| — | Director | 32,781 | — |
| — | 10%+ Owner | 23,847 | — |
| — | Director | 22,203 | — |
| — | Director | 19,317 | — |
| — | Director | 18,585 | — |
| — | Director | 17,748 | — |
| — | See remarks | 14,803 | — |
| — | Director | 9,643 | — |
| — | Chief Medical Officer | 5,000 | — |
| — | Director | 4,761 | — |
| — | Director | 4,559 | — |
| — | Chief Accounting Officer | 4,419 | — |
| — | Chief Commercial Officer | 4,254 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MRNA quote page; the site-wide leaderboard is on the insider transactions hub.